RB1 and cancer: Consistently, the phosphorylation of pRb at Ser807/811, two of the residues that need to be phosphorylated for lifting its suppressive effect on E2F-induced gene transcription [28], was remarkably reduced by the administration of Efipladib when the quiescent cancer cells were permitted to re-enter cell cycle (Figure 7).